Navigation Links
SFC Fluidics, Inc. Receives SBIR Phase II Funding for Development of an Implantable Drug Delivery Device
Date:8/30/2017

SFC Fluidics® is very pleased to announce it has received $1.4 million in Phase II Small Business Innovation Research funding from the National Institutes of Health for the development of an implantable, wirelessly controlled, rapid dosing drug delivery system for small animal research. The min-ePump™ implantable drug delivery device will allow real-time, remote controlled delivery of drugs and therapeutics to animal models for addiction and behavior research studies. This system will allow for improved testing methods, as currently animals are required to be tethered to a pump and tested in isolation.

Key research areas that can benefit from untethered animal behavior models include substance abuse, mood disorders, schizophrenia, choice behavior, sleep behavior, stimulus response, relapse, anxiety, avoidance, PTSD, chronic stress, aggressive behavior, cognition, depression, Alzheimer’s disease, Parkinson’s disease, aging disorders, and management of chronic pain in humans. Additionally, the min-ePump™ will provide tremendous advantages for the development of a simple patch pump and artificial pancreas for people with diabetes. This technology will allow for miniaturization that will offer people with diabetes a new level of convenience and discretion to manage the disease.

SFC Fluidics, Inc. has a mission to advance healthcare and improve quality of life through our enabling microfluidic technologies. The company’s vision is to become a recognized global leader in the drug delivery and health monitoring markets where our unique product lines improve lifestyle and affordability. SFC Fluidics® is a VIC Technology Venture Development™ portfolio company.

Research reported in this release was supported by The National Institute on Drug Abuse of the National Institutes of Health under grant number [2R44DA041173-02]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Read the full story at http://www.prweb.com/releases/SFCFluidicsDeveloping/ImplantForDrugDelivery/prweb14639592.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Heidelberg Instruments receives orders for advanced VPG+ Volume Pattern Generator from two Asian based photomask suppliers
2. Worcester Polytechnic Institute Receives National Institutes of Health Funding to Develop a Heart Muscle Patch
3. Benchworks Receives Industry Accolades
4. Kibow Biotech Inc. (Buzz of Bio Winner, 2014) Receives US Patent for Gout/Hyperuricemia Product Formulation Based on Modulation of the Gut Microbiome With Probiotics and Prebiotics
5. Heidelberg Instruments receives order for an advanced VPG Large Area Volume Pattern Generator
6. G-CON Manufacturing CEO Receives Recognition as a Top Pharmaceutical Industry Influencer
7. Worcester Polytechnic Institute Receives $1.6 million NIH Award to Study Gender Differences in Neurobiology
8. Singota™ Solutions CEO Receives 2017 Distinguished Alumni Award
9. Prometic Receives $9.5 Million Purchase Order From Multinational Client
10. Intralytix Receives FDA Regulatory Clearance for Phage-Based Shigella Technology
11. Bactana Animal Health Receives Patent Notice of Allowance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2018)... ... July 25, 2018 , ... John McDonald, CEO of ... of the Indiana India Business Council (IIBC), an advocacy group to strengthen economic ... board of directors, McDonald joins an impressive roster of local and national business ...
(Date:7/24/2018)... ... July 24, 2018 , ... Boval was founded in ... bank reagent suppliers. In Boval’s early days most of the BSA manufactured was ... produce BSA for diagnostic purposes after gel cards changed that market and displaced most ...
(Date:7/22/2018)... ... 2018 , ... Mitotech S.A, a Luxembourg based clinical stage ... clinical program in Dry Eye Disease. Under the agreement Essex Bio-Investment will fund ... the first Phase 3 study starting as early as Fall 2018. , ...
(Date:7/22/2018)... ... July 21, 2018 , ... Today the Weed Science Society of America (WSSA) ... dicamba herbicides is available on the Society’s website . The workshop was designed ... understand and manage factors contributing to dicamba off-target movement. , Dicamba herbicide ...
Breaking Biology Technology:
(Date:8/2/2018)... (PRWEB) , ... August 02, 2018 , ... ... addition of heart health innovator Boston Heart Diagnostics to its Lifestyle Medicine Corporate ... health, a sustainable health care system and a sustainable world. , Boston ...
(Date:8/1/2018)... ... August 01, 2018 , ... ... RN’s, LPN’s, MA's and Administrative staff. , This full day course is an ... The course will expose your staff to regenerative medicine procedures and processing techniques, ...
(Date:7/31/2018)... RIVER FALLS, Wis. (PRWEB) , ... July 31, 2018 , ... ... a distribution agreement with Batory Foods effective July 1, 2018. Over the years, Fiberstar ... sales momentum and to penetrate the food and beverage market, Fiberstar partnered up with ...
Breaking Biology News(10 mins):